Charles E DiLiberti

Title: Innovations by Charles E DiLiberti

Introduction

Charles E DiLiberti is a notable inventor based in Montclair, NJ (US), recognized for his contributions to pharmaceutical innovations. With a total of five patents to his name, DiLiberti has made significant strides in the field of medicine, particularly in dosage forms and symptom management.

Latest Patents

One of his latest patents is focused on methods of reducing symptoms in subjects using single dosage forms with tapering release rates. This invention aims to alleviate symptoms associated with abrupt reductions in endogenous or exogenous chemicals by administering a single dosage form that releases an active agent at a tapering rate. The method includes removing the dosage form once the release rate is at or below a terminal symptom threshold level. Another significant patent involves oral dosage forms comprising progesterone, which includes micronized progesterone, an edible oil, a disintegrant, and a hydrophilic excipient. This invention is particularly relevant for creating a pharmaceutical dosage form in powder form contained within a pharmaceutically acceptable capsule, along with methods of making and using the dosage form.

Career Highlights

Throughout his career, Charles E DiLiberti has worked with prominent companies such as Teva Women's Health, Inc. and Teva Woman's Health, Inc. His work in these organizations has contributed to the development of innovative health solutions.

Collaborations

DiLiberti has collaborated with notable colleagues, including Kathleen Z Reape and Lance J Bronnenkant, enhancing the impact of his inventions through teamwork and shared expertise.

Conclusion

Charles E DiLiberti's innovative work in the pharmaceutical field demonstrates his commitment to improving health outcomes through effective dosage forms and symptom management strategies. His contributions continue to influence the industry positively.